v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (48,349) $ (46,014)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 9,321 8,614
Depreciation and amortization 244 343
Amortization of right-of-use asset - operating 379 285
Loss on disposal of property and equipment   2
Accretion of discount on marketable securities, net (88)  
Change in operating assets and liabilities:    
Prepaid and other assets (635) 1,052
Accounts payable, accrued and other liabilities 3,166 (4,240)
Lease liabilities (412) (398)
Other long-term liabilities   40
Net cash used in operating activities (36,374) (40,316)
Cash flows from investing activities:    
Purchases of marketable securities (12,804)  
Maturities of marketable securities 1,000  
Purchases of property and equipment (40) (37)
Net cash used in investing activities (11,844) (37)
Cash flows from financing activities:    
Payment of issuance costs associated with the 2026 Private Placement (9,591)  
Proceeds from sale of stock under the employee stock purchase plan 203  
Payment of issuance costs associated with the Concurrent Financing   (37)
Payment of reverse recapitalization transaction costs   (40)
Net cash provided by (used in) financing activities 140,611 (77)
Net increase (decrease) in cash and cash equivalents 92,393 (40,430)
Cash and cash equivalents, beginning of period 59,050 110,761
Cash and cash equivalents, end of period 151,443 70,331
Supplemental disclosure of noncash financing activities:    
Purchases of property and equipment in accounts payable   $ 3
Leased assets obtained in exchange for operating lease liabilities, upon extension 653  
2026 Private Placement    
Cash flows from financing activities:    
Proceeds from the issuance of Class A Common Stock and pre-funded warrants in connection with 2026 Private Placement $ 149,999